Scholar Rock Holding Corporation
Status: Publicly traded
Direct answer
Scholar Rock Holding Corporation is publicly traded on NASDAQ under the ticker SRRK.
Scholar Rock Holding Corporation is a biopharmaceutical firm dedicated to discovering and advancing treatments for severe medical conditions by targeting the crucial role of protein growth factor signaling. Their lead therapeutic candidate, Apitegromab, an agent designed to inhibit the activation of latent myostatin, has successfully concluded Phase 3 clinical trials for spinal muscular atrophy (SMA). Another key...
Can you invest in Scholar Rock Holding Corporation?
Yes. Scholar Rock Holding Corporation trades publicly on NASDAQ as SRRK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Scholar Rock Holding Corporation
Detailed equity research is provided by MarketSnap.